Group 1 - The company plans to establish a wholly-owned subsidiary in Hainan or Hunan provinces to engage in the cell industry and related mergers and acquisitions [1] - The registered capital for the new subsidiary will be 100 million yuan [1] - This move aims to strengthen the company's positioning in the cell industry and create a second growth curve for the company [1]

人民财讯9月24日电，开能健康（300272）9月24日公告，根据公司双能驱动的长期战略规划，公司拟在 海南省或湖南省等地区设立全资子公司从事细胞行业业务及行业并购事宜，全资子公司注册资本1亿 元。 ...

Group 1 - The company plans to establish a wholly-owned subsidiary in Hainan or Hunan provinces to engage in the cell industry and related mergers and acquisitions [1] - The registered capital of the new subsidiary will be 100 million yuan [1] - This move aims to strengthen the company's positioning in the cell industry and create a second growth curve for the company [1]

每经AI快讯，开能健康（SZ 300272，收盘价：6.46元）9月24日晚间发布公告称，根据公司双能驱动的 长期战略规划，公司拟以自有资金在海南省或湖南省等地区设立全资子公司从事细胞行业业务及行业并 购事宜，全资子公司注册资本为1亿元人民币。 2024年1至12月份，开能健康的营业收入构成为：环保设备制造及服务行业占比100.0%。 截至发稿，开能健康市值为40亿元。 每经头条（nbdtoutiao）——"9·24"一周年，A股总市值破116万亿元！四大变革重塑中国资本市场新生 态 （记者 曾健辉） ...

Core Viewpoint - The company plans to establish a wholly-owned subsidiary, Kaineng Cell Medical Group Co., Ltd., in Hainan or Hunan Province with a registered capital of 100 million RMB to enhance its presence in the cell industry and pursue industry mergers and acquisitions [1] Group 1 - The subsidiary will focus on cell industry operations and related mergers and acquisitions [1] - The investment will be funded by the company's own resources, and the transaction does not require board approval, nor does it constitute a related party transaction or a major asset restructuring [1] - This initiative aims to strengthen the company's positioning in the cell industry, creating a second growth curve for the company [1]

证券代码：300272 证券简称：开能健康 公告编号：2025-082 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 开能健康科技集团股份有限公司（以下简称"公司"）拟对外投资设立全资 子公司，现将相关情况公告如下： 一、对外投资概述 根据公司双能驱动的长期战略规划，公司拟以自有资金在海南省或湖南省等 地区设立全资子公司从事细胞行业业务（最终以工商登记为准）及行业并购事宜， 全资子公司注册资本为 10,000 万元人民币。 公司本次对外投资资金来源为自有资金，根据《公司章程》相关规定，本次 交易在总经理审批权限范围内，无需提交董事会审议。本次交易不构成关联交易， 也不构成《上市公司重大资产重组管理办法》规定的重大资产重组或重组上市， 不需要经过有关部门的批准。 三、对外投资的目的、对公司的影响和存在的风险 公司本次设立全资子公司是围绕公司"双能驱动"发展战略进行，加强开能 健康在细胞产业的布局，进入细胞行业业务及行业并购，从而打造细胞产业为公 司的第二增长曲线。 本次投资风险可控，投资资金来源于公司自有资金，不会影响公司生产经营 活动和现金流的正常运转，不会 ...

Market Overview - The Shanghai Composite Index closed at 3853.44 points, above the annual line, with a gain of 0.83% [1] - The total trading volume of A-shares reached 1,894.457 billion yuan [1] Stocks Breaking Annual Line - A total of 153 A-shares have surpassed the annual line today, with notable stocks including Yunnan City Investment, Maiwei Co., and Dongsoft Zhaibo, showing significant deviation rates of 7.64%, 7.27%, and 5.57% respectively [1] - Stocks with smaller deviation rates that have just crossed the annual line include Jiuyuan Yinhai, Jida Communication, and Shanghai Jiubai [1] Top Stocks by Deviation Rate - Yunnan City Investment (600239) reported a daily increase of 10.16% with a deviation rate of 7.64% [1] - Maiwei Co. (300751) saw an 8.63% increase and a deviation rate of 7.27% [1] - Dongsoft Zhaibo (300183) increased by 5.91% with a deviation rate of 5.57% [1] Additional Notable Stocks - Nanjing Public Utilities (000421) increased by 5.03% with a deviation rate of 4.79% [1] - Suzhou High-tech (600736) rose by 4.86% with a deviation rate of 4.69% [1] - Other stocks with notable performance include Shunyu Co. (301519) and Leshi Xin (688631) with increases of 5.40% and 6.79% respectively [1]

Core Points - The Shanghai Composite Index closed at 3845.91 points, above the annual line, with a gain of 0.63% [1] - The total trading volume of A-shares reached 1,420.282 billion yuan [1] - A total of 131 A-shares have surpassed the annual line, with notable stocks showing significant deviation rates [1] Summary by Category Stock Performance - The stocks with the highest deviation rates from the annual line include: - Maiwei Co., Ltd. (300751) with a deviation rate of 8.90% and a daily increase of 10.29% [1] - Yunnan City Investment (600239) with a deviation rate of 7.64% and a daily increase of 10.16% [1] - Dongsoft Zhaibo (300183) with a deviation rate of 6.03% and a daily increase of 6.38% [1] Trading Activity - The trading turnover rates for the top stocks include: - Maiwei Co., Ltd. at 4.74% [1] - Yunnan City Investment at 4.25% [1] - Dongsoft Zhaibo at 4.67% [1] Additional Notable Stocks - Other stocks that have recently crossed the annual line with lower deviation rates include: - Nanjing Public Utilities (000421) with a deviation rate of 4.63% [1] - Suzhou High-tech (600736) with a deviation rate of 4.52% [1] - Fuguang Co., Ltd. (688010) with a deviation rate of 4.06% [1]

证券日报网讯开能健康（300272）9月22日在互动平台回答投资者提问时表示，截至9月19日，公司股东 总户数22，064户。 ...

Market Overview - The small home appliance sector experienced a decline of 1.47% on September 12, with Ecovacs leading the drop [1] - The Shanghai Composite Index closed at 3883.69, up 0.22%, while the Shenzhen Component Index closed at 12996.38, up 0.13% [1] Stock Performance - Notable gainers included: - Fuhua Co., Ltd. (603219) with a closing price of 18.72, up 2.80% [1] - Jizhi Technology (870726) at 21.19, up 0.95% [1] - Kaineng Health (300272) at 6.73, up 0.75% [1] - Major decliners included: - Ecovacs (603486) at 98.73, down 1.71% [2] - Dechang Co., Ltd. (605555) at 17.40, down 1.53% [2] - Xiaoxiong Electric (002959) at 54.90, down 1.38% [2] Capital Flow - The small home appliance sector saw a net outflow of 10.27 million yuan from institutional investors, while retail investors experienced a net outflow of 93.34 million yuan [2] - Conversely, speculative funds recorded a net inflow of 104 million yuan [2] Individual Stock Capital Flow - Fuhua Co., Ltd. (603219) had a net outflow of 38.21 million yuan from institutional investors, while it saw a net inflow of 24.31 million yuan from speculative funds [3] - Ecovacs (603486) had a net outflow of 38.1 million yuan from institutional investors [3] - Suo Boer (002032) recorded a net inflow of 10.76 million yuan from institutional investors [3]